文献速递肾移植肾血管病与高血压

肾移植受者血压目标与结局:协作移植研究分析

Blood Pressure Goals and Outcomes in Kidney Transplant Recipients in an Analysis of the Collaborative Transplant Study.
PubMed 文献 · Kidney Int Rep · 2024-12-06

这项大规模回顾性研究分析协作移植研究数据库中39个国家209个中心62556例肾移植受者移植后1年血压数据,按ACC/AHA血压分类评估对移植肾存活和患者死亡的影响。结果显示77%受者存在高血压,1级和2级高血压分别与死亡删失的移植肾衰竭风险增加11%和55%相关,患者死亡仅在2级高血压显著增加。

要点

  • 移植后1年77%肾移植受者存在高血压。
  • 2级高血压与死亡删失的移植肾衰竭风险增加55%相关。
  • 患者死亡仅在2级高血压时显著增加。

核心结论

  • 本研究强调肾移植后早期高血压的不良影响,并强调有效治疗对改善长期移植肾和患者存活的重要性。

研究设计与样本

  • 大规模回顾性研究,纳入39个国家209个中心62556例肾移植受者移植后1年血压数据,使用协作移植研究(CTS)数据库。
  • 主要结局为移植后前6年死亡删失的移植肾衰竭和患者死亡,采用多变量Cox回归控制多种免疫和非免疫混杂因素。

主要发现

  • 移植后1年77%的肾移植受者存在高血压。
  • 血压正常(<120/<80 mm Hg)与血压升高(120-129/<80 mm Hg)患者间死亡删失的移植肾衰竭和患者死亡无显著差异。
  • 1级高血压(130-139/80-89 mm Hg)与死亡删失的移植肾衰竭风险增加11%相关,2级高血压(≥140/≥90 mm Hg)与增加55%相关。
  • 患者死亡仅在2级高血压者中显著增加。
  • 2级高血压的肾移植受者即使在移植后第2年达到正常血压,移植肾衰竭风险仍持续增加。

关键数值与推荐

  • 血压分类采用美国心脏病学会和美国心脏学会(ACC/AHA)标准:正常<120/<80 mm Hg,血压升高120-129/<80 mm Hg,1级高血压130-139/80-89 mm Hg,2级高血压≥140/≥90 mm Hg。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Hypertension is an independent risk factor for cardiovascular disease, the leading cause of death in kidney transplant recipients. However, optimal blood pressure targets posttransplant remain uncertain. We investigated the impact of different American College of Cardiology and the American Heart Association (ACC/AHA) blood pressure categories on graft survival and patient mortality, and analyzed subgroup-specific effects. METHODS: This large-scale retrospective study included 1-year blood pressure data from 62,556 kidney transplant recipients across 209 centers in 39 countries, using the collaborative transplant study (CTS) database. Primary outcomes were death-censored graft failure and patient mortality during first 6 years posttransplantation. Multivariable Cox regression analysis controlled for multiple immunological and nonimmunological confounders. RESULTS: At 1 year posttransplant, 77% of kidney transplant recipients had hypertension. We did not find a significant difference in death-censored graft failure and patient mortality between patients with normal blood pressure (< 120/< 80 mm Hg) and those with elevated blood pressure (120-129/< 80 mm Hg). Hypertension stages 1 (130-139/80-89 mm Hg) and 2 (≥ 140/≥ 90 mm Hg) were associated with an 11% and 55% increased risk of death-censored graft failure, respectively. Patient mortality was only significantly increased in those with hypertension stage 2. Kidney transplant recipients with hypertension stage 2 continued to have an increased risk of graft failure, even when they achieved normal blood pressure in the second year posttransplant. Certain subgroups of patients were at particularly high risk of detrimental effects of high blood pressure. CONCLUSION: This study highlights the negative impact of hypertension early after kidney transplantation and emphasizes the importance of effective treatment to improve long-term graft and patient survival.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Speer C, Benning L, Morath C, et al. Blood Pressure Goals and Outcomes in Kidney Transplant Recipients in an Analysis of the Collaborative Transplant Study. Kidney Int Rep. 2024. PMID: 40225383. doi:10.1016/j.ekir.2024.12.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。